IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pharmstandard International S.A.

Q3 2017 Holdings

Filed 2017-11-03 | 5 holdings | $34.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Protagonist Therapeutics, Inc.(PTGX)Common74366E102$17.4K982,27050.6%
Jounce Therapeutics, Inc.(JNCEEUR)Common481116101$10.3K662,06330.1%
Proteon Therapeutics Inc.Common74371L109$3.3K1,667,9079.7%
Argos Therapeutics Inc.Common040221103$2.4K13,242,2796.9%
Argos Therapeutics Inc.CallCommon040221103$9195,120,6042.7%